Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
2. Flomax
3. Ly 253352
4. Ly-253352
5. Tamsulosin
6. Ym 617
7. Ym-617
1. 106463-17-6
2. Flomax
3. Tamsulosin Hcl
4. Omnic
5. Pradif
6. Harnal
7. Urolosin
8. Secotex
9. Josir
10. Alna
11. Omic
12. Omix
13. Ym617
14. Ly253351
15. Amsulosin Hydrochloride
16. Tamsulosin (hydrochloride)
17. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
18. R-(-)-ym-12617
19. Ym 617
20. Ym-12617-1
21. Ym-617
22. Ly-253351
23. Chebi:9399
24. (-)-(r)-5-(2-((2-(o-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Monohydrochloride
25. 11sv1951mr
26. 5-[(2r)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride
27. 5-[(2r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide;hydrochloride
28. 5-[(r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamide Hydrochloride
29. R-(-)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
30. Expros
31. Flomax (tn)
32. Dsstox_cid_26628
33. Dsstox_rid_81777
34. Dsstox_gsid_46628
35. 128332-25-2
36. Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, Monohydrochloride, (r)-
37. (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide Hydrochloride
38. (-)-(r)-5-(2-((2-(o-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzene Sulfonamide Monohydrochloride
39. Cas-106463-17-6
40. Tamsulosine Hydrochloride
41. Ncgc00167442-01
42. Mfcd00922997
43. (r)-tamsulosin Hydrochloride
44. Unii-11sv1951mr
45. Tamsulosin.hcl
46. Harnalidge Ocas
47. Flomax Mr
48. Alnaocas
49. 5-[(2r)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide Hydrochloride
50. Flomax Hydrochloride
51. Harnal (tn)
52. Tamsulosin Hydrochloride [usan:usp:jan]
53. Tamsulosina Hydrochloride
54. Tamsulosinum Hydrochloride
55. (-)-ly 253352
56. Schembl23428
57. Tamsulosin Hydrochloride,(s)
58. Mls003899197
59. Racemic Tamsulosin Hydrochloride
60. Chembl1200914
61. Dtxsid2046628
62. Hy-b0661a
63. 5-[(2rs)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride (tamsulosin Racemate Hydrochloride)
64. Tox21_112446
65. Eu-617
66. S4729
67. (r)-tamsulosin Hydrochloride- Bio-x
68. Tamsulosin Hydrochloride (jp17/usp)
69. Tamsulosin Hydrochloride [jan]
70. Akos015895342
71. Akos015995287
72. Tox21_112446_1
73. Bs-1019
74. Ccg-269178
75. Tamsulosin Hydrochloride [usan]
76. (-)-ly253352
77. Tamsulosin Hydrochloride [mart.]
78. Tamsulosin Hydrochloride [vandf]
79. Ncgc00167442-03
80. Tamsulosin Hydrochloride [usp-rs]
81. Tamsulosin Hydrochloride [who-dd]
82. Bt164440
83. Smr002543366
84. Bcp0726000042
85. Tamsulosin Hydrochloride, >=98% (hplc)
86. T2749
87. Y-617
88. Tamsulosin Hydrochloride [orange Book]
89. A14936
90. D01024
91. Jalyn Component Tamsulosin Hydrochloride
92. Tamsulosin Hydrochloride [ep Monograph]
93. Tamsulosin Hydrochloride [usp Impurity]
94. Tamsulosin Hydrochloride [usp Monograph]
95. 463t176
96. A801444
97. Tamsulosin Hydrochloride Component Of Jalyn
98. Q-201777
99. (r)-(-)-ym12617;ly253351
100. (r)-5-(2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2
101. Q27108379
102. Tamsulosin Hydrochloride, British Pharmacopoeia (bp) Reference Standard
103. Tamsulosin Hydrochloride, European Pharmacopoeia (ep) Reference Standard
104. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Hcl
105. 5-((2r)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzene-sulfonamide Hcl
106. 5-[(r)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]]-2-methoxybenzenesulfonamidehydrochloride
107. Tamsulosin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
108. Tamsulosin Hydrochloride, United States Pharmacopeia (usp) Reference Standard
109. (r)-5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide Monohydrochloride
110. 5-[(2r)-2-[[2-(-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzenesulfonamide Hydrochloride;tamsulosin Hcl
| Molecular Weight | 445.0 g/mol |
|---|---|
| Molecular Formula | C20H29ClN2O5S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 11 |
| Exact Mass | 444.1485709 g/mol |
| Monoisotopic Mass | 444.1485709 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 539 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 4 | |
|---|---|
| Drug Name | Flomax |
| PubMed Health | Tamsulosin (By mouth) |
| Drug Classes | Benign Prostatic Hypertrophy Agent |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 0.4mg |
| Market Status | Prescription |
| Company | Boehringer Ingelheim |
| 2 of 4 | |
|---|---|
| Drug Name | Tamsulosin hydrochloride |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | oral; Oral |
| Strength | 0.4mg |
| Market Status | Tentative Approval; Prescription |
| Company | Synthon Pharms; Anchen Pharms; Wockhardt; Ranbaxy; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Teva Pharms; Zydus Pharms Usa; Mylan; Impax Labs |
| 3 of 4 | |
|---|---|
| Drug Name | Flomax |
| PubMed Health | Tamsulosin (By mouth) |
| Drug Classes | Benign Prostatic Hypertrophy Agent |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 0.4mg |
| Market Status | Prescription |
| Company | Boehringer Ingelheim |
| 4 of 4 | |
|---|---|
| Drug Name | Tamsulosin hydrochloride |
| Drug Label | Tamsulosin hydrochloride is an antagonist of alpha1A adrenoceptors in the prostate.Tamsulosin hydrochloride is (-)-(R)-5-[2-[[2-(o-Ethoxyphenoxy) ethyl]amino]propyl]-2-methoxybenzenesulfonamide, monohydrochloride. Tamsulosin hydrochloride is a white... |
| Active Ingredient | Tamsulosin hydrochloride |
| Dosage Form | Capsule |
| Route | oral; Oral |
| Strength | 0.4mg |
| Market Status | Tentative Approval; Prescription |
| Company | Synthon Pharms; Anchen Pharms; Wockhardt; Ranbaxy; Aurobindo Pharma; Sun Pharm Inds; Sandoz; Teva Pharms; Zydus Pharms Usa; Mylan; Impax Labs |
Urological Agents
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - CAPSULE;ORAL - 0.4MG
USFDA APPLICATION NUMBER - 20579
DOSAGE - CAPSULE;ORAL - 0.5MG;0.4MG
USFDA APPLICATION NUMBER - 22460
Related Excipient Companies
EUROAPI
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Evonik
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Rochem International Inc
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Boai NKY Pharmaceuticals Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Alcedo Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Doshion Polyscience
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Huzhou Sunflower Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Bold Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Valens Pharmachem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Excipients by Applications
Coating Systems & Additives
Controlled & Modified Release
Fillers, Diluents & Binders
Thickeners and Stabilizers
Solubilizers
Film Formers & Plasticizers
Lubricants & Glidants
Taste Masking
Direct Compression
Topical
Granulation
Parenteral
Co-Processed Excipients
Emulsifying Agents
Empty Capsules
Disintegrants & Superdisintegrants
Rheology Modifiers
Chewable & Orodispersible Aids
API Stability Enhancers
Coloring Agents
Vegetarian Capsules
Surfactant & Foaming Agents
Soft Gelatin
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
USP
ANALYTICAL
ABOUT THIS PAGE
32
PharmaCompass offers a list of Tamsulosin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tamsulosin manufacturer or Tamsulosin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tamsulosin manufacturer or Tamsulosin supplier.
PharmaCompass also assists you with knowing the Tamsulosin API Price utilized in the formulation of products. Tamsulosin API Price is not always fixed or binding as the Tamsulosin Price is obtained through a variety of data sources. The Tamsulosin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 106138-88-9 (Parent) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 106138-88-9 (Parent), including repackagers and relabelers. The FDA regulates 106138-88-9 (Parent) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 106138-88-9 (Parent) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of 106138-88-9 (Parent) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A 106138-88-9 (Parent) supplier is an individual or a company that provides 106138-88-9 (Parent) active pharmaceutical ingredient (API) or 106138-88-9 (Parent) finished formulations upon request. The 106138-88-9 (Parent) suppliers may include 106138-88-9 (Parent) API manufacturers, exporters, distributors and traders.
click here to find a list of 106138-88-9 (Parent) suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A 106138-88-9 (Parent) DMF (Drug Master File) is a document detailing the whole manufacturing process of 106138-88-9 (Parent) active pharmaceutical ingredient (API) in detail. Different forms of 106138-88-9 (Parent) DMFs exist exist since differing nations have different regulations, such as 106138-88-9 (Parent) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 106138-88-9 (Parent) DMF submitted to regulatory agencies in the US is known as a USDMF. 106138-88-9 (Parent) USDMF includes data on 106138-88-9 (Parent)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 106138-88-9 (Parent) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 106138-88-9 (Parent) suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The 106138-88-9 (Parent) Drug Master File in Japan (106138-88-9 (Parent) JDMF) empowers 106138-88-9 (Parent) API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the 106138-88-9 (Parent) JDMF during the approval evaluation for pharmaceutical products. At the time of 106138-88-9 (Parent) JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of 106138-88-9 (Parent) suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a 106138-88-9 (Parent) Drug Master File in Korea (106138-88-9 (Parent) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of 106138-88-9 (Parent). The MFDS reviews the 106138-88-9 (Parent) KDMF as part of the drug registration process and uses the information provided in the 106138-88-9 (Parent) KDMF to evaluate the safety and efficacy of the drug.
After submitting a 106138-88-9 (Parent) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their 106138-88-9 (Parent) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of 106138-88-9 (Parent) suppliers with KDMF on PharmaCompass.
A 106138-88-9 (Parent) CEP of the European Pharmacopoeia monograph is often referred to as a 106138-88-9 (Parent) Certificate of Suitability (COS). The purpose of a 106138-88-9 (Parent) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 106138-88-9 (Parent) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 106138-88-9 (Parent) to their clients by showing that a 106138-88-9 (Parent) CEP has been issued for it. The manufacturer submits a 106138-88-9 (Parent) CEP (COS) as part of the market authorization procedure, and it takes on the role of a 106138-88-9 (Parent) CEP holder for the record. Additionally, the data presented in the 106138-88-9 (Parent) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 106138-88-9 (Parent) DMF.
A 106138-88-9 (Parent) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 106138-88-9 (Parent) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 106138-88-9 (Parent) suppliers with CEP (COS) on PharmaCompass.
A 106138-88-9 (Parent) written confirmation (106138-88-9 (Parent) WC) is an official document issued by a regulatory agency to a 106138-88-9 (Parent) manufacturer, verifying that the manufacturing facility of a 106138-88-9 (Parent) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting 106138-88-9 (Parent) APIs or 106138-88-9 (Parent) finished pharmaceutical products to another nation, regulatory agencies frequently require a 106138-88-9 (Parent) WC (written confirmation) as part of the regulatory process.
click here to find a list of 106138-88-9 (Parent) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing 106138-88-9 (Parent) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for 106138-88-9 (Parent) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture 106138-88-9 (Parent) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain 106138-88-9 (Parent) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a 106138-88-9 (Parent) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of 106138-88-9 (Parent) suppliers with NDC on PharmaCompass.
106138-88-9 (Parent) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 106138-88-9 (Parent) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 106138-88-9 (Parent) GMP manufacturer or 106138-88-9 (Parent) GMP API supplier for your needs.
A 106138-88-9 (Parent) CoA (Certificate of Analysis) is a formal document that attests to 106138-88-9 (Parent)'s compliance with 106138-88-9 (Parent) specifications and serves as a tool for batch-level quality control.
106138-88-9 (Parent) CoA mostly includes findings from lab analyses of a specific batch. For each 106138-88-9 (Parent) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
106138-88-9 (Parent) may be tested according to a variety of international standards, such as European Pharmacopoeia (106138-88-9 (Parent) EP), 106138-88-9 (Parent) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (106138-88-9 (Parent) USP).
